Linden Buys Hycor from Agilent

Linden LLC, a Chicago-based health care private equity firm, has purchased Hycor Biomedical Inc. from Agilent Technologies for an undisclosed amount.

Hycor, located in Garden Grove, Calif., manufactures in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets. Agilent origianlly bought Hycor through its 2007 acquisition of Stratagene.

“We believe Hycor has great opportunities outside of the Agilent portfolio,” said Nick Roelofs, president of Agilent’s Life Sciences Group. “Hycor is an innovative, profitable and growing business, but it does not fit the core focus of our life science business. Agilent is pleased that Linden is the buyer because of its strong health care and diagnostics expertise coupled with its track record of investing in and growing businesses.”

Richard Novak, a Linden operating partner and former chief operating officer of Laboratory Corporation of America, will serve as Hycor's chairman.

For more information, visit: www.agilent.com